Nexgel Inc (NXGL)

Name: Nexgel Inc (NXGL) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Nexgel Inc (NXGL)

Stock Card

$0.32

$-0.02 (-6.75%)

As on 04-Sep-2026 16:00EDT

Market cap

$3 Mln

Revenue (TTM)

$12 Mln

P/E Ratio

P/B Ratio

0.7

Div. Yield

0 %

Nexgel Inc (NXGL) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.31 High: 0.34

52 Week Range

Low: 0.30 High: 2.89

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.2 %
ROCE

-- %
Industry P/E

37.91
EV/EBITDA

-0.9
Debt to Equity

0.7
Book Value

$0.5
EPS

$-0.7
Face value

--
Shares outstanding

9,747,663

8 Years Aggregate

CFO

$-16.23 Mln

EBITDA

$-16.35 Mln

Net Profit

$-24.43 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Nexgel Inc (NXGL)	-80.3	-25.2	-46.0	-86.2	-49.9	--	--
BSE Sensex^*	-10.1	-3.6	2.5	-5.7	4.9	5.5	10.1
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 04-Sep-2026 | *As on 07-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023
Nexgel Inc (NXGL)	-63.9	108.1	70.4
S&P Small-Cap 600	4.0	7.0	13.9
BSE Sensex	9.1	8.1	18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Nexgel Inc (NXGL)	0.3	3.1	12.1	-6.2	-31.3	-134.3	--	0.7
Amneal Pharmaceuticals Inc Class A (AMRX)	17.4	6,074.3	3,117.6	157.4	14.7	--	36.3	188.5
Axsome Therapeutics (AXSM)	206.7	10,826.1	776.6	-191.6	-17.6	-223.4	--	131.0
BridgeBio Pharma (BBIO)	74.8	14,630.7	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	111.6	12,065.9	830.8	54.9	3.2	8.1	248	17.3
Dr. Reddy's Laboratories - ADR	12.0	10,020.9	332,834.2	33,166.6	11.1	8.9	29.3	2.5
Elanco Animal Health (ELAN)	24.5	12,236.5	5,020.0	-199.0	1.6	-3	--	1.9
Ligand Pharmaceuticals (LGND)	285.6	5,693.6	290.5	197.2	82.5	19.9	29.8	5.9
Liquidia Technologies Inc (LQDA)	68.7	6,145.7	450.9	138.6	39.1	115.6	49	30.7
Twist Bioscience Corp (TWST)	124.7	8,210.6	431.8	-136.7	-30.8	-30.3	--	19.0

Shareholding Pattern

View Details

About Nexgel Inc (NXGL)

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments:... Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania. Read more

CEO, President & Director

Mr. Adam R. Levy
CEO, President & Director

Mr. Adam R. Levy
Headquarters

Langhorne, PA
Website

https://nexgel.com

FAQs for Nexgel Inc (NXGL)

What is the current share price of Nexgel Inc (NXGL) Today?

The share price of Nexgel Inc (NXGL) is $0.32 (NASDAQ) as of 04-Sep-2026 16:00 EDT. Nexgel Inc (NXGL) has given a return of -49.92% in the last 3 years.

What is the current PB & PE ratio of Nexgel Inc (NXGL)?

Since, TTM earnings of Nexgel Inc (NXGL) is negative, P/E ratio is not available.
The P/B ratio of Nexgel Inc (NXGL) is 0.70 times as on 04-Sep-2026, a 91 discount to its peers’ median range of 7.69 times.

PE & PB ratio at the end of financial year.